Bryan Johnson, Psilocybin, and the Biology of Letting Go
What the most quantified psychedelic experiment ever tells us about aging, rigidity, and renewal
By Joseph Santiago
Founder, Microdose Bros
For decades, psychedelics have been described using language science struggles to contain: insight, ego dissolution, afterglow, rebirth. Powerful words—but slippery ones.
Bryan Johnson does not traffic in slippery language.
As the founder of Kernel and the architect of Blueprint, Johnson has made himself one of the most measured humans in history. His life is an ongoing experiment in longevity, optimization, and biological precision. Brain activity, blood chemistry, hormones, metabolism—everything is tracked, quantified, and interrogated.
So when Bryan Johnson publicly released data from a psilocybin experiment, it mattered.
Not because it was psychedelic.
But because it was measured.
In his own words, this was “the most quantified psychedelic experiment ever done.”
What follows is not a story about belief.
It is a story about patterns.
About Bryan Johnson
Bryan Johnson is an American entrepreneur, venture capitalist, writer, and bio-optimization pioneer who has become one of the most talked-about figures in tech and longevity. He first made his name in the tech world by founding Braintree, a payments company that acquired Venmo and was later sold to PayPal — a deal that helped establish his financial foundation and credibility in Silicon Valley. After exiting Braintree, Johnson turned his attention to some of the biggest unanswered questions about human potential. He founded Kernel, a neurotechnology company developing devices to monitor and record brain activity, and the OS Fund, which backs early-stage science and technology startups.
More recently, Johnson has become a public face of radical longevity experimentation through a project he calls Project Blueprint, an intensely quantified anti-aging regimen that includes strict diet protocols, extensive testing, and lifestyle interventions designed to optimize biological age. His efforts — documented in the 2025 Netflix documentary Don’t Die: The Man Who Wants to Live Forever — have drawn millions of viewers and sparked global discussion about aging, biology, and what it means to push human limits. Johnson’s social media presence, including over 2 million followers on Instagram and threads where he shares raw data and detailed insights, reflects his commitment to transparency and personal science, even as his methods and goals remain the subject of debate and fascination. You can follow him on Instagram here: https://www.instagram.com/bryanjohnson
The Experiment: Precision Meets Psychedelics
(And why preparation matters as much as the molecule)
Bryan Johnson conducted two high-dose psilocybin sessions, spaced three weeks apart.
That spacing is not incidental.
Psilocybin primarily acts on 5-HT2A serotonin receptors, triggering temporary reorganization of brain networks and nervous system signaling. After a significant psychedelic experience, receptors, circuits, and meaning-making processes need time to down-regulate, integrate, and stabilize.
In psychedelic science, this spacing matters because plasticity needs room to settle. Without adequate space, sensitivity can blunt and integration can fragment.
Johnson’s protocol reflected this understanding.
The Substance: Psilocybe cubensis (B+ Variety)
Both sessions used dried, powdered Psilocybe cubensis, specifically the B+ strain.
This detail is important.
B+ is not an obscure or extreme variety. It is one of the most widely cultivated strains in the world—and for good reason. It is often described as:
- Balanced and emotionally expansive
- Clear rather than overwhelming
- Insight-oriented without excessive cognitive distortion
- Well-suited for reflection, openness, and creative exploration
Consistency matters in research, and B+ is known for its reliability.
At Microdose Bros, we offer the B+ Magic Mushroom Grow Kit, allowing people to engage with the organism from the ground up—literally.
👉 https://www.microdosebros.com/store/b-magic-mushroom-grow-kit
Cultivating a mushroom is not about potency. It is about relationship, patience, and respect—qualities that shape how experiences are later held and integrated.
Dose Details
First dose (Nov 9):
• 4.67 g dried B+
• ~24.98 mg psilocybin
• ~3.5 mg psilocin
• Private setting, guided
Second dose (Nov 30):
• 5.35 g dried B+
• ~28 mg psilocybin
• ~4 mg psilocin
• More open setting, with friends and family joining virtually
These were substantial doses, chosen to induce a full neuroplastic event rather than a subtle perceptual shift.
But dose alone does not tell the story.
Creating Space for the Receptors: Why Preparation Matters
Psilocybin does not enter a neutral system.
It enters a body that is fed or fasted, stressed or rested, inflamed or regulated. The internal physiological state shapes how the experience unfolds as much as mindset or environment.
Johnson dissolved the doses in citrus juice—orange juice for the first session, lemon juice for the second—a practice commonly known as Lemon Tek.
For a deeper explanation, we’ve broken this down here:
👉 https://www.microdosebros.com/what-is-lemon-tek-pros-and-cons-of-soaking-psilocybin-magic-truffles-in-lemon-juice/
This choice was not about intensifying effects. It was about biological clarity.
Why Lemon Juice?
Johnson cited two primary reasons.
1. Preserving the active compounds
Lemon juice is more acidic than orange juice. This acidity slows premature conversion of psilocybin into psilocin before ingestion, helping preserve more psilocybin until it reaches the body, where conversion can occur under the body’s own enzymatic control.
In simple terms: less degradation, more predictability.
2. Metabolic stability
Lemon juice contains roughly 70% less sugar and 45% fewer calories than orange juice. For someone tracking glucose continuously, this matters. Johnson aimed to maintain a fasting-like metabolic state and minimize glucose spikes that could confound his data.
This was not optimization for intensity—it was respect for the system.
What Changed in the Brain: From Control to Connectivity
Kernel Flow measurements revealed profound shifts in brain organization.
Johnson observed:
- Inhibition of default mode and command networks, including the prefrontal cortex
- Increased functional connectivity and hyperintegration across sensory, motor, auditory, and speech networks
- A shift toward a more entropic brain state—open, flexible, exploratory, creative
Three weeks later, baseline measurements still showed lingering effects from the first dose. After the second dose, post-peak measurements indicated additive effects, with heightened sensory-motor and language network activation—coinciding with a setting rich in emotional expression and social connection.
This matters because psychedelics do not operate in isolation.
Context shapes circuitry.
A Surprise Outside the Brain: Metabolism
Perhaps the most unexpected findings had nothing to do with consciousness.
Using continuous glucose monitoring, Johnson documented a dramatic improvement in blood sugar control.
Comparing three days before and after dosing:
- Mean glucose dropped 8%, reaching 80.84 mg/dL (a personal best)
- Glucose fluctuation dropped 11%, indicating smoother metabolic control
- Estimated HbA1c dropped from 4.7% to 4.4%
- Glucose control shifted from the top 2% to the top 0.2% of the population, outperforming 99.75% of healthy 18–25-year-olds
- Effects remained durable through Day 3 post-dose
Johnson described this as a possible metabolic reset, triggered by a neuroplastic event.
If replicated, this could reshape how we think about metabolic regulation—not as a purely chemical process, but as a neurologically mediated one.
Inflammation: Quieting the Signal
Systemic inflammation is a key driver of aging.
Johnson tracked hsCRP (high-sensitivity C-reactive protein):
- Five days after the first dose, hsCRP dropped to below detectable levels (<0.15 mg/dL)
- Three days after the second dose, hsCRP remained low at 0.18 mg/dL, still a 22% reduction from baseline
Other inflammatory markers, such as TNF-alpha, remained stable. Future sessions will include broader cytokine panels.
This suggests regulation, not suppression—a calming of background biological noise.
Stress Hormones and the Afterglow
Cortisol followed a pattern familiar to many experienced users, but rarely quantified:
- Cortisol spiked sharply during the acute phase
- Levels returned to baseline before sleep
- Five days post-dose:
- Morning cortisol dropped 42%
- DHEA-S dropped 45%
- Estradiol increased 200%, consistent with known 5-HT2A–aromatase pathways
This reflects a temporary stress response followed by sustained relaxation—the biological signature of what many call the “afterglow.”
Not stimulation.
Recovery.
Heat, the Body, and Emotional Intensity
For the first time, Johnson’s team produced thermal maps of a psychedelic experience.
Findings included:
- Core temperature increase of 1.5–2°F during peak
- Heat redistribution toward the core
- Patterns consistent with 5-HT2A-mediated autonomic activation
- Thermal signatures correlating with joy, insight, and subtle melancholy
Psychedelics are embodied experiences. The nervous system is not a passenger—it is the terrain.
Placing This Within the Psychedelic Canon
None of this exists in isolation.
For decades, psychedelics have been associated with openness, emotional flexibility, and lasting perspective shifts. What Bryan Johnson adds is biological coherence.
Across brain networks, metabolism, inflammation, and stress signaling, the direction was the same:
→ Away from rigidity
→ Toward flexibility
→ Away from chronic activation
→ Toward regulated recovery
If aging is the slow accumulation of fixed patterns, then health may be the ability to temporarily loosen the system so it can reorganize itself.
What This Does Not Mean
This experiment does not mean:
- That psilocybin is a longevity therapy
- That more is better
- That this should be replicated casually
- That microdosing and macrodosing are interchangeable
This was n = 1 data, offered with scientific humility. Dose, preparation, setting, and integration mattered enormously.
What this provides is not instruction—but insight.
Reflections for the Reader
Rather than conclusions, consider questions:
- After meaningful psychedelic experiences, what changes lingered longer than expected?
- Did your relationship to stress, food, or sleep subtly shift?
- Did flexibility increase—or did sensitivity increase first?
- What helped those changes integrate into daily life?
These questions matter more than metrics.
Why This Matters to Our Community
At Microdose Bros, we’ve long believed that psilocybin is not about escape—it’s about reconnection. Not forcing change, but allowing the system to reorganize when the conditions are right.
Bryan Johnson’s data gives scientific language to what many people already sense intuitively: that under the right circumstances, psychedelics may help the body and mind remember how to self-regulate.
If you’re curious about gentle, intentional entry points into this space, you can explore our McMicrodose Starter Kit here:
👉 https://www.microdosebros.com/store/mcmicrodose-starter-kit-featuring-6-individual-1-gram-truffles/
And if you want to stay connected to our ongoing conversations around science, consciousness, and responsible use, you can follow us on Instagram:
👉 https://instagram.com/microdosebros
A Closing Thought
Bryan Johnson did not prove that psilocybin is a longevity therapy.
He did something more valuable.
He measured what happens when control loosens—just enough—for the system to breathe.
And in a world obsessed with optimization, that may be the most radical data point of all.
—
Joseph Santiago
Founder, Microdose Bros
